Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force

[1]  Iris R. Mabry-Hernandez,et al.  Screening for Lipid Disorders in Children and Adolescents. , 2017, American family physician.

[2]  S. Haymond,et al.  Pediatric lipid screening rates in the US are low: what can labs do to help? , 2015, Clinical chemistry.

[3]  B. Hutten,et al.  Early initiation of statin treatment in children with familial hypercholesterolaemia , 2015, Current opinion in lipidology.

[4]  D. Gaudet,et al.  PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.

[5]  R. V. van Schaik,et al.  POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemia. , 2014, Pharmacogenomics.

[6]  J. Zachariah,et al.  Pediatric lipid management: an earlier approach. , 2014, Endocrinology and metabolism clinics of North America.

[7]  K. Widhalm,et al.  Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study , 2014, European Journal of Clinical Nutrition.

[8]  David M. Herrington,et al.  Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction , 2014, Nature.

[9]  B. Falkner,et al.  A double-blind randomized trial of fish oil to lower triglycerides and improve cardiometabolic risk in adolescents. , 2014, The Journal of pediatrics.

[10]  N. Shafiq,et al.  Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia. , 2014, The Cochrane database of systematic reviews.

[11]  F. V. van Bockxmeer,et al.  Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner. , 2014, Atherosclerosis.

[12]  M. Varghese.  Familial hypercholesterolemia: A review , 2014, Annals of pediatric cardiology.

[13]  Bechien U. Wu,et al.  Simvastatin is associated with reduced risk of acute pancreatitis: findings from a regional integrated healthcare system , 2014, Gut.

[14]  G. Radaelli,et al.  Blood lipids profile in hyperlipidemic children undergoing different dietary long chain polyunsaturated supplementations: a preliminary clinical trial , 2014, International journal of food sciences and nutrition.

[15]  S. Gidding,et al.  Learning more about dyslipidemia in childhood. , 2014, The Journal of pediatrics.

[16]  J. Borén,et al.  Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. , 2014, Atherosclerosis.

[17]  Ž. Reiner.  Impact of Early Evidence of Atherosclerotic Changes on Early Treatment in Children With Familial Hypercholesterolemia , 2014, Circulation research.

[18]  M. Elkind,et al.  Review of Lipid and Lipoprotein(a) Abnormalities in Childhood Arterial Ischemic Stroke , 2014, International journal of stroke : official journal of the International Stroke Society.

[19]  M. Blaha,et al.  Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. , 2013, JAMA.

[20]  N. Tandon,et al.  Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR) , 2013, Journal of pediatric endocrinology & metabolism : JPEM.

[21]  P. Joshi,et al.  Very Large Database of Lipids: Rationale and Design , 2013, Clinical cardiology.

[22]  R. B. Canani,et al.  Efficacy of a new symbiotic formulation containing Lactobacillus paracasei B21060 in children with familial hypercholesterolemia , 2013 .

[23]  F. Raal,et al.  Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia , 2013, Circulation.

[24]  V. Capuano,et al.  The safety of statins in children , 2013, Acta paediatrica.

[25]  T. Teramoto,et al.  Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia. , 2013, Atherosclerosis.

[26]  Zheng Chen,et al.  Glycolipid metabolic status of overweight/obese adolescents aged 9- to 15-year-old and the BMI-SDS/BMI cut-off value of predicting dyslipidemiain boys, Shanghai, China: a cross-sectional study , 2013, Lipids in Health and Disease.

[27]  Catherine Boileau,et al.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease , 2013, European heart journal.

[28]  M. Davidson.  The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients. , 2013, Clinical therapeutics.

[29]  M. Flechtner-Mors,et al.  Screening for Co-Morbidity in 65,397 Obese Pediatric Patients from Germany, Austria and Switzerland: Adherence to Guidelines Improved from the Year 2000 to 2010 , 2013, Obesity Facts.

[30]  B. McCrindle,et al.  Flaxseed in pediatric hyperlipidemia: a placebo-controlled, blinded, randomized clinical trial of dietary flaxseed supplementation for children and adolescents with hypercholesterolemia. , 2013, JAMA pediatrics.

[31]  L. Ose,et al.  Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia , 2013, Expert review of cardiovascular therapy.

[32]  D. Lawlor,et al.  Waist-to-height ratio and cardiometabolic risk factors in adolescence: findings from a prospective birth cohort , 2013, Pediatric obesity.

[33]  B. French,et al.  Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial. , 2013, American heart journal.

[34]  F. Visioli,et al.  Could dyslipidemic children benefit from glucomannan intake? , 2013, Nutrition.

[35]  N. Schork,et al.  Genomic Risk Models Improve Prediction of Longitudinal Lipid Levels in Children and Young Adults , 2013, Front. Genet..

[36]  E. Stein,et al.  Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades , 2013, Cardiology in the Young.

[37]  T. A. Jacobson,et al.  Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatin , 2013, Current medical research and opinion.

[38]  M. Gastonguay,et al.  Population Pharmacokinetics of Atorvastatin and Its Active Metabolites in Children and Adolescents With Heterozygous Familial Hypercholesterolemia: Selective Use of Informative Prior Distributions from Adults , 2013, Journal of clinical pharmacology.

[39]  R. Kelishadi,et al.  Investigation of the Lipid-Modifying and Antiinflammatory Effects of Cornus mas L. Supplementation on Dyslipidemic Children and Adolescents , 2013, Pediatric Cardiology.

[40]  S. Prakash,et al.  Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial. , 2013, The Journal of clinical endocrinology and metabolism.

[41]  Sonia Shah,et al.  Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study , 2013, The Lancet.

[42]  O. Guardamagna,et al.  Management of Inherited Atherogenic Dyslipidemias in Children , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[43]  G. Watts,et al.  Familial hypercholesterolaemia in children and adolescents: A new paediatric model of care , 2013, Journal of paediatrics and child health.

[44]  S. Humphries,et al.  Statin treatment of children with familial hypercholesterolemia--trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus? , 2013, Atherosclerosis.

[45]  Duolao Wang,et al.  Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: a pilot study , 2013, Nutrition Journal.

[46]  K. Kohara,et al.  Predictive Value of the Low-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio for the Prevention of Stroke Recurrence in Japanese Patients Treated with Rosuvastatin , 2012, Clinical Drug Investigation.

[47]  S. Wasserman,et al.  Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study , 2012, The Lancet.

[48]  S. Gidding,et al.  Universal Screening of Cholesterol in Children , 2012, Clinical cardiology.

[49]  P. McBride,et al.  Should family physicians routinely screen for hypercholesterolemia in children? Yes: the evidence supports universal screening. , 2012, American family physician.

[50]  D. Vlahov,et al.  Cardiovascular disease risk assessment and prevention in blood donors , 2012, Transfusion.

[51]  C. Molinari,et al.  Dyslipidemia without obesity in indigenous Argentinean children living at high altitude. , 2012, The Journal of pediatrics.

[52]  L. Whitehead,et al.  Using the experiences of people with familial hypercholesterolaemia to help reduce the risk of cardiovascular disease: a qualitative systematic review. , 2012, Journal of advanced nursing.

[53]  H. S. Brown,et al.  Missed Opportunities for Diagnosis and Treatment of Diabetes, Hypertension, and Hypercholesterolemia in a Mexican American Population, Cameron County Hispanic Cohort, 2003–2008 , 2012, Preventing chronic disease.

[54]  J. Wilkinson,et al.  Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs? , 2012, Pediatric endocrinology reviews : PER.

[55]  A. Saenger.  Universal lipid screening in children and adolescents: a baby step toward primordial prevention? , 2012, Clinical chemistry.

[56]  S. Shulman.  Screening all children for lipid disorders. , 2012, Pediatric annals.

[57]  B. Okopień,et al.  The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia , 2012, Fundamental & clinical pharmacology.

[58]  S. Chiplonkar,et al.  Relationship between body mass index, fat distribution and cardiometabolic risk factors in Indian children and adolescents , 2012, Pediatric obesity.

[59]  C. Ballantyne,et al.  Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia. , 2012, Journal of clinical lipidology.

[60]  W. Neal,et al.  Screening children for hyperlipidemia by primary care physicians in West Virginia. , 2012, The West Virginia medical journal.

[61]  O. Harrison,et al.  Weqaya: a population-wide cardiovascular screening program in Abu Dhabi, United Arab Emirates. , 2012, American journal of public health.

[62]  H. McShane,et al.  Incidental Diagnosis in Healthy Clinical Trial Subjects , 2012, Clinical and translational science.

[63]  S. Daniels.  Management of hyperlipidemia in pediatrics , 2012, Current opinion in cardiology.

[64]  C. Ballantyne,et al.  Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction. , 2012, Journal of clinical lipidology.

[65]  J. Tomassini,et al.  Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial , 2012, Diabetes Care.

[66]  M. Linton,et al.  Dyslipidemias in children. , 2012, Pediatric annals.

[67]  G. Watts,et al.  Screening for familial hypercholesterolaemia , 2012, Pathology.

[68]  M. Netea,et al.  Improved access to life insurance after genetic diagnosis of familial hypercholesterolaemia: cross-sectional postal questionnaire study , 2012, European Journal of Human Genetics.

[69]  Lea S. Eiland,et al.  Use of statins for dyslipidemia in the pediatric population. , 2011, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

[70]  Gert B. M. Mensink,et al.  Indicators of Overweight and Cardiovascular Disease Risk Factors among 11- to 17-Year-Old Boys and Girls in Germany , 2011, Obesity Facts.

[71]  C. de Beaufort,et al.  Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. , 2011, Atherosclerosis.

[72]  C. de Beaufort,et al.  Paediatric screening for hypercholesterolaemia in Europe , 2011, Archives of Disease in Childhood.

[73]  E. Spoerl,et al.  Statins affect ocular microcirculation in patients with hypercholesterolaemia , 2011, Acta ophthalmologica.

[74]  A. Aggarwal,et al.  Lipoprotein (a)--lipid profile and apolipoprotein B in children of young parents with coronary artery disease. , 2011, Indian heart journal.

[75]  G. Anfossi,et al.  Lipoprotein(a) and family history of cardiovascular disease in children with familial dyslipidemias. , 2011, The Journal of pediatrics.

[76]  K. Flegal,et al.  Association of body fat percentage with lipid concentrations in children and adolescents: United States, 1999-2004. , 2011, The American journal of clinical nutrition.

[77]  S. Daniels,et al.  Screening and Treatment of Dyslipidemias in Children and Adolescents , 2011, Hormone Research in Paediatrics.

[78]  M. Trevisan,et al.  Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction , 2011, Journal of cardiovascular medicine.

[79]  Richard Kones,et al.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey , 2011, Drug design, development and therapy.

[80]  E. Guallar,et al.  Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) , 2011, Lipids in Health and Disease.

[81]  S. Daniels,et al.  Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. , 2011, Journal of clinical lipidology.

[82]  C. Molinari,et al.  Comparison of different anthropometric indices for identifying dyslipidemia in school children. , 2011, Clinical biochemistry.

[83]  J. Tur,et al.  Metabolic syndrome in adolescents in the Balearic Islands, a Mediterranean region. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[84]  R. Halpern,et al.  Associated factors to total cholesterol: school based study in southern Brazil. , 2011, Arquivos brasileiros de cardiologia.

[85]  W. Neal,et al.  Morbidly obese diagnosis as an indicator of cardiovascular disease risk in children: results from the CARDIAC Project. , 2011, International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity.

[86]  C. Gibson,et al.  The high-dose rosuvastatin once weekly study (the HD-ROWS). , 2011, Journal of clinical lipidology.

[87]  M. Davidson.  A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia. , 2011, Journal of clinical lipidology.

[88]  R. Wanders,et al.  Rosuvastatin lowers coenzyme Q10 levels, but not mitochondrial adenosine triphosphate synthesis, in children with familial hypercholesterolemia. , 2011, The Journal of pediatrics.

[89]  P. Glasziou,et al.  The rise of cholesterol testing: how much is unnecessary. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[90]  M. F. Cardoso,et al.  Impact of academic exposure on health status of university students. , 2011, Revista de saude publica.

[91]  A. Thompson,et al.  Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[92]  L. Kheirandish-Gozal,et al.  Insulin Sensitivity, Serum Lipids, and Systemic Inflammatory Markers in School-Aged Obese and Nonobese Children , 2011, International journal of pediatrics.

[93]  Y. Fujita,et al.  Height-Specific Serum Cholesterol Levels in Pubertal Children: Data From Population-Based Japanese School Screening , 2011, Journal of Epidemiology.

[94]  Michael G. M. Derks,et al.  Lack of clinically relevant drug-drug interactions when dalcetrapib is co-administered with ezetimibe. , 2010, British journal of clinical pharmacology.

[95]  M. Viigimaa,et al.  Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency , 2010, Lipids in Health and Disease.

[96]  J. I. Pedersen,et al.  Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study , 2010, European Journal of Epidemiology.

[97]  M. Mitka.  Screening misses high LDL in many youths. , 2010, JAMA.

[98]  Robert L Gauer.  Hyperlipidemia treatment in children: the younger, the better. , 2010, American family physician.

[99]  R. Campbell,et al.  Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children , 2010, Adolescent health, medicine and therapeutics.

[100]  Feng Lin,et al.  Nonoptimal Lipids Commonly Present in Young Adults and Coronary Calcium Later in Life: The CARDIA (Coronary Artery Risk Development in Young Adults) Study , 2010, Annals of Internal Medicine.

[101]  W. Neal,et al.  Universal Versus Targeted Blood Cholesterol Screening Among Youth: The CARDIAC Project , 2010, Pediatrics.

[102]  R. Jago,et al.  Fatness, fitness, and cardiometabolic risk factors among sixth-grade youth. , 2010, Medicine and science in sports and exercise.

[103]  A. Zaninelli,et al.  Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients. , 2010, Journal of clinical lipidology.

[104]  Raffaele Izzo,et al.  Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia , 2010, Journal of hypertension.

[105]  G. Meneses‐Lorente,et al.  Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing , 2010, European Journal of Clinical Pharmacology.

[106]  H. Szajewska,et al.  Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials , 2010, Archives of Disease in Childhood.

[107]  Anand Rohatgi.  Cholesterol screening in children: makes sense but what is the impact? , 2010, Future cardiology.

[108]  A. Alegría,et al.  Effects of phytosterol ester-enriched low-fat milk on serum lipoprotein profile in mildly hypercholesterolaemic patients are not related to dietary cholesterol or saturated fat intake , 2010, British Journal of Nutrition.

[109]  J. Paolini,et al.  Efficacy and safety of extended‐release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia , 2010, International journal of clinical practice.

[110]  C. Mendivil,et al.  Cardiovascular risk factors and metabolic syndrome in a population of young students from the National University of Colombia. , 2010, Revista da Associacao Medica Brasileira.

[111]  P. Saavedra-Santana,et al.  HDL Cholesterol Levels in Children with Mild Hypercholesterolemia: Effect of Consuming Skim Milk Enriched with Olive Oil and Modulation by the TAQ 1B Polymorphism in the CETP Gene , 2010, Annals of Nutrition and Metabolism.

[112]  N. Akar,et al.  Lipoprotein (a) Levels in Childhood Arterial Ischemic Stroke , 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[113]  M. Eriksson,et al.  Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. , 2010, Clinical therapeutics.

[114]  C. Perry.  Colesevelam , 2010, Paediatric drugs.

[115]  Y. Fujita,et al.  Trends in Body Mass Index, Blood Pressure, and Serum Lipids in Japanese Children: Iwata Population-Based Annual Screening (1993–2008) , 2010, Journal of epidemiology.

[116]  J. Brug,et al.  A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial , 2010, BMC public health.

[117]  J. Tomassini,et al.  Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia. , 2010, The American journal of cardiology.

[118]  D. Noto,et al.  Plasma Non–cholesterol Sterols: A Useful Diagnostic Tool in Pediatric Hypercholesterolemia , 2010, Pediatric Research.

[119]  F. Tao,et al.  Normal reference values for serum lipid levels in Chinese adolescents between 12 and 18 years of age. , 2010, Journal of tropical pediatrics.

[120]  M. Hallikainen,et al.  The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins. , 2010, Clinical nutrition.

[121]  N. Shafiq,et al.  Dietary treatment for familial hypercholesterolaemia. , 2010, The Cochrane database of systematic reviews.

[122]  Baracco,et al.  The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[123]  J. Kastelein,et al.  Heterozygous familial hypercholesterolaemia in childhood: Cardiovascular risk prevention , 2009, Journal of Inherited Metabolic Disease.

[124]  H. Bonkovsky,et al.  Drug-Induced Liver Injury Associated with Statins , 2009, Seminars in liver disease.

[125]  M. Steiner,et al.  Short-term change in body mass index in overweight adolescents following cholesterol screening. , 2009, Archives of pediatrics & adolescent medicine.

[126]  Jie-shi Zhang,et al.  Prevalence of abnormity of blood lipid and associated factors in health examination population in Beijing. , 2009, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[127]  Chao-shu Tang,et al.  Profiles of levels of lipids and dyslipidaemia in children from Beijing, China , 2009, Cardiology in the Young.

[128]  C. Tan,et al.  Effects of rosuvastatin on low-density lipoprotein cholesterol and plasma lipids in Asian patients with hypercholesterolemia. , 2009, Journal of atherosclerosis and thrombosis.

[129]  G. Gensini,et al.  International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[130]  Terho Lehtimäki,et al.  Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young Adults: The Cardiovascular Risk in Young Finns Study , 2009, Circulation.

[131]  R. Karas,et al.  Association between statin-associated myopathy and skeletal muscle damage , 2009, Canadian Medical Association Journal.

[132]  D. Labarthe,et al.  Evaluation of AAP guidelines for cholesterol screening in youth: Project HeartBeat! , 2009, American journal of preventive medicine.

[133]  Kirk A. Jenkins,et al.  Cardiovascular risk profile: comparison between white and Southeast Asian youth in Wausau SCHOOL Project. , 2009, WMJ : official publication of the State Medical Society of Wisconsin.

[134]  J. Viikari,et al.  Expression of common familial dyslipidemias in early childhood. , 2009, Atherosclerosis.

[135]  R. Kavey,et al.  Ezetimibe treatment of pediatric patients with hypercholesterolemia. , 2009, The Journal of pediatrics.

[136]  J. Shield,et al.  Hypercholesterolaemia in children guidelines review , 2009, Archives of Disease in Childhood - Education and Practice.

[137]  F. Carrat,et al.  Diagnosis Scoring for Clinical Identification of Children With Heterozygous Familial Hypercholesterolemia , 2009, Journal of pediatric gastroenterology and nutrition.

[138]  Mark Avigan,et al.  Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors , 2009, Pharmacoepidemiology and drug safety.

[139]  R. Kelishadi,et al.  Factor Analysis of Markers of Inflammation and Oxidation and Echocardiographic Findings in Children with a Positive Family History of Premature Coronary Heart Disease , 2009, Pediatric Cardiology.

[140]  M. Higgins,et al.  Systematic Review and Metaanalysis of Statins for Heterozygous Familial Hypercholesterolemia in Children: Evaluation of Cholesterol Changes and Side Effects , 2009, Pediatric Cardiology.

[141]  A. Day,et al.  Efficacy of alternate day versus daily dosing of rosuvastatin. , 2009, The Canadian journal of cardiology.

[142]  S. King,et al.  Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia. , 2009, The American journal of cardiology.

[143]  G. Tamburlini,et al.  Statins for children? A word of caution , 2009, European Journal of Clinical Pharmacology.

[144]  S. G. Hadfield,et al.  Family tracing to identify patients with Familial Hypercholesterolaemia: the second Audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project , 2009, Annals of clinical biochemistry.

[145]  A. Wilde,et al.  Predictive genetic testing for cardiovascular diseases: Impact on carrier children , 2008, American journal of medical genetics. Part A.

[146]  M. Jacobson,et al.  Screening adolescents for lipid disorders: what is the best approach? , 2008, Adolescent medicine: state of the art reviews.

[147]  Jennifer S. Li,et al.  Prevention of future cardiovascular disease in high-risk pediatric patients: a role for lipid lowering therapy? , 2008, Circulation. Cardiovascular quality and outcomes.

[148]  P. Kwiterovich.  Recognition and management of dyslipidemia in children and adolescents. , 2008, The Journal of clinical endocrinology and metabolism.

[149]  Emilio Ros,et al.  Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. , 2008, The American journal of cardiology.

[150]  S. Humphries,et al.  Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study , 2008, European heart journal.

[151]  Y. Koutedakis,et al.  Longitudinal preventive-screening cutoffs for metabolic syndrome in adolescents , 2008, International Journal of Obesity.

[152]  Y. Ohashi,et al.  Practical risk prediction tools for coronary heart disease in mild to moderate hypercholesterolemia in Japan: originated from the MEGA study data. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[153]  M. Trevisan,et al.  Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[154]  P. Codoñer-Franch,et al.  Mandarin Juice Improves the Antioxidant Status of Hypercholesterolemic Children , 2008, Journal of pediatric gastroenterology and nutrition.

[155]  D. Kamerow.  Should we screen for and treat childhood dyslipidaemia? , 2008, BMJ : British Medical Journal.

[156]  T. Laitinen,et al.  Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. , 2008, Journal of the American College of Cardiology.

[157]  S. Daniels,et al.  Lipid Screening and Cardiovascular Health in Childhood , 2008, Pediatrics.

[158]  M. Trip,et al.  Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia. , 2008, The Journal of pediatrics.

[159]  B. Browne,et al.  Pediatric dyslipidemias: Prescription medication efficacy and safety. , 2008, Journal of clinical lipidology.

[160]  J. Zidan,et al.  Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin. , 2008, British journal of clinical pharmacology.

[161]  M. Bond,et al.  Usefulness of Childhood Non–High Density Lipoprotein Cholesterol Levels Versus Other Lipoprotein Measures in Predicting Adult Subclinical Atherosclerosis: The Bogalusa Heart Study , 2008, Pediatrics.

[162]  P. Durrington,et al.  Patients’ Understandings and Experiences of Familial Hypercholesterolemia , 2008, Public Health Genomics.

[163]  M. O’Grady,et al.  Cholesterol Screening in an At-Risk Pediatric Population , 2008, Pediatric Cardiology.

[164]  J. Tomassini,et al.  Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. , 2008, Journal of the American College of Cardiology.

[165]  D. Liebeskind,et al.  Association of serum lipid indices with large artery atherosclerotic stroke , 2008, Neurology.

[166]  S. Daniels.  Screening for familial hypercholesterolemia: what is the most effective strategy? , 2008, Nature Clinical Practice Cardiovascular Medicine.

[167]  D. Rader,et al.  A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia. , 2008, Atherosclerosis.

[168]  A. Coşkun.  Preanalytical factors for non-HDL cholesterol measurements/ Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children. , 2008, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[169]  K. Widhalm,et al.  Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet , 2008, British Journal of Nutrition.

[170]  R. Ferré,et al.  Plant sterol-enriched fermented milk enhances the attainment of LDL-cholesterol goal in hypercholesterolemic subjects , 2008, European journal of nutrition.

[171]  M. Warner.  Child–parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis , 2008, Annals of clinical biochemistry.

[172]  A. Farmer,et al.  Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. , 2007, Atherosclerosis.

[173]  E. Fisher,et al.  Therapeutic approach to childhood hypercholesterolemia. , 2007, Pediatric endocrinology reviews : PER.

[174]  M. Bláha,et al.  Primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia: A prospective pilot trial using PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure , 2007, Hematology.

[175]  F. N. Aksakal,et al.  Cholesterol screening in school children: is family history reliable to choose the ones to screen? , 2007, Acta paediatrica.

[176]  K. Malterud,et al.  Experiences of guilt and shame in patients with familial hypercholesterolemia: a qualitative interview study. , 2007, Patient education and counseling.

[177]  N. Shafiq,et al.  A meta-analysis to evaluate the efficacy of statins in children with familial hypercholesterolemia. , 2007, International journal of clinical pharmacology and therapeutics.

[178]  E. Stein.  Statins and children: whom do we treat and when? , 2007, Circulation.

[179]  M. Trip,et al.  A Systematic Review and Meta-Analysis of Statin Therapy in Children With Familial Hypercholesterolemia , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[180]  N. Rifai,et al.  Nonfasting Low-Density Lipoprotein Testing: Utility for Cholesterol Screening in Pediatric Primary Care , 2007, Clinical pediatrics.

[181]  T. Ohta,et al.  Birthweight and risk factors for cardiovascular diseases in Japanese schoolchildren , 2007, Pediatrics international : official journal of the Japan Pediatric Society.

[182]  D. Vidt,et al.  Safety of Rosuvastatin: Update on 16,876 Rosuvastatin-Treated Patients in a Multinational Clinical Trial Program , 2007, Cardiology.

[183]  K. Widhalm,et al.  Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations , 2007, Journal of Inherited Metabolic Disease.

[184]  N. Kapur.  Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease , 2007, Expert review of cardiovascular therapy.

[185]  H. Takase,et al.  Effects of phytosterols in diacylglycerol as part of diet therapy on hyperlipidemia in children. , 2007, Asia Pacific journal of clinical nutrition.

[186]  J. Shim,et al.  Association between brachial-ankle pulse wave velocity and cardiovascular risk factors in healthy adolescents. , 2007, The Journal of pediatrics.

[187]  R. Vasan,et al.  Risk factors for acute ischaemic stroke in young adults in South India , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[188]  R. Krauss,et al.  Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel , 2006, Journal of internal medicine.

[189]  E. Boerwinkle,et al.  APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study Published, JLR Papers in Press, December 16, 2004. DOI 10.1194/jlr.M400437-JLR200 , 2005, Journal of Lipid Research.

[190]  S. Gapstur,et al.  Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young black men and white men: the CARDIA Male Hormone Study. , 2004, American journal of epidemiology.

[191]  Richard Kahn,et al.  Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association , 2004, Stroke.

[192]  E. Levy,et al.  Usefulness of the American Academy of Pediatrics recommendations for identifying youths with hypercholesterolemia. , 2004, Pediatrics.

[193]  E. Demerath,et al.  School-based obesity screening in rural Appalachia. , 2003, Preventive medicine.

[194]  M. Grootenhuis,et al.  Quality of life, anxiety and concerns among statin‐treated children with familial hypercholesterolaemia and their parents. , 2003, Acta paediatrica.

[195]  Jonathan D. Cohen,et al.  Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. , 2003, The Journal of clinical investigation.

[196]  K. Widhalm,et al.  The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation , 2003, European Journal of Pediatrics.

[197]  V. Hubbard,et al.  Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. , 2002, Obesity research.

[198]  R. Cuena,et al.  High density lipoprotein-cholesterol changes in children with high cholesterol levels at birth , 2002, European Journal of Pediatrics.

[199]  J. Strong,et al.  Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[200]  S. Humphries,et al.  Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study , 2000, BMJ : British Medical Journal.

[201]  T. Peters,et al.  Screening for hypercholesterolaemia in 10,000 neonates in a multi-ethnic population , 1999, European Journal of Pediatrics.

[202]  S. McHale,et al.  Psychosocial factors in nutrition education for hypercholesterolemic children , 1998, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[203]  N. Rifai,et al.  Utility of direct measurement of low-density lipoprotein cholesterol in dyslipidemic pediatric patients. , 1998, Archives of pediatrics & adolescent medicine.

[204]  R. Tracy,et al.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.

[205]  S. Tonstad,et al.  The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine. , 1998, The Journal of pediatrics.

[206]  V. Stevens,et al.  Effects of diet and sexual maturation on low-density lipoprotein cholesterol during puberty: the Dietary Intervention Study in Children (DISC). , 1997, Circulation.

[207]  G. Bosco,et al.  Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood. , 1997, Drugs under experimental and clinical research.

[208]  E. Stone,et al.  Parent and physician response to children's cholesterol values of 200 mg/dL or greater: the Child and Adolescent Trial for Cardiovascular Health Experiment. , 1997, Pediatrics.

[209]  D. Lamping,et al.  Cholesterol screening of children at high risk: behavioural and psychological effects. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[210]  B. McCrindle,et al.  Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. , 1997, The Journal of pediatrics.

[211]  S. Tonstad.  Familial hypercholesterolaemia: a pilot study of parents’and children's concerns , 1996, Acta paediatrica.

[212]  S. Tonstad,et al.  Colestipol tablets in adolescents with familial hypercholesterolaemia , 1996, Acta paediatrica.

[213]  E. Rimm,et al.  Failure of current guidelines for cholesterol screening in urban African-American adolescents. , 1996, Pediatrics.

[214]  S. Tonstad,et al.  Psychosocial function during treatment for familial hypercholesterolemia. , 1996, Pediatrics.

[215]  E. Rimm,et al.  Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population. , 1996, Clinical chemistry.

[216]  J. T. Clarke,et al.  Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. , 1996, Pediatrics.

[217]  I. Benuck.  Cholesterol screening in children. , 1995, Current problems in pediatrics.

[218]  Z. Schlesinger,et al.  Lipid profile with paternal history of coronary heart disease before age 40. , 1995, Archives of disease in childhood.

[219]  G. Huster,et al.  Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents. , 1995, The Journal of pediatrics.

[220]  J. Viikari,et al.  Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns study. , 1994, American journal of epidemiology.

[221]  P. Stolley,et al.  Reduction of elevated LDL-cholesterol levels of 4- to 10-year-old children through home-based dietary education. , 1994, Pediatrics.

[222]  T. Pearson,et al.  Challenges to implementing the current pediatric cholesterol screening guidelines into practice. , 1994, Pediatrics.

[223]  J. Strain,et al.  Cholesterol screening and family history of vascular disease. , 1994, Archives of disease in childhood.

[224]  R. Rona,et al.  Response to venepuncture for monitoring in primary schools. , 1994, Archives of disease in childhood.

[225]  R. Karp,et al.  Family history of coronary artery disease and cholesterol: screening children in a disadvantaged inner-city population. , 1994, Pediatrics.

[226]  Y. Ikeda,et al.  Follow up study on children with dyslipidaemia detected by mass screening at 18 months of age: effect of 12 months dietary treatment , 1993, European Journal of Pediatrics.

[227]  D. Cross,et al.  Evaluation of a school-site cardiovascular risk factor screening intervention. , 1993, Preventive medicine.

[228]  R. Croyle,et al.  Psychological minimization of cholesterol test results: moderators of appraisal in college students and community residents. , 1993, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[229]  M. Leppert,et al.  Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. , 1993, The American journal of cardiology.

[230]  J. Newburger,et al.  Niacin treatment of hypercholesterolemia in children. , 1993, Pediatrics.

[231]  M. Glassman,et al.  Cholesterol screening in children: should obesity be a risk factor? , 1993, Journal of the American College of Nutrition.

[232]  E. Schoen,et al.  Compliance with childhood cholesterol screening among members of a prepaid health plan. , 1993, American journal of diseases of children.

[233]  J. Cortner,et al.  Use of cholestyramine in the treatment of children with familial combined hyperlipidemia. , 1993, The Journal of pediatrics.

[234]  S. Rosenthal,et al.  The Psychological Functioning of Children with Hypercholesterolemia and Their Families , 1993, Clinical pediatrics.

[235]  D. Sprecher,et al.  Primary hyperlipidemia in a pediatric population: classification and effect of dietary treatment. , 1993, Pediatrics.

[236]  T. Peters,et al.  Neonatal screening for familial hypercholesterolaemia by immunoturbidimetric assay of apolipoprotein B in dried blood spots. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[237]  K. Michaelsen,et al.  Growth during treatment of familial hypercholesterolemia , 1992, Acta paediatrica.

[238]  L. Cupples,et al.  Impact of within-person variability on identifying children with hypercholesterolemia: Framingham Children's Study. , 1992, The Journal of pediatrics.

[239]  B. Koletzko,et al.  Treatment of hypercholesterolemia in children and adolescents , 1992, Acta paediatrica.

[240]  N. Wong,et al.  Television viewing and pediatric hypercholesterolemia. , 1992, Pediatrics.

[241]  E. Muls,et al.  Simvastatin use in children , 1992, The Lancet.

[242]  C. Lannon,et al.  Parents' behavior and attitudes toward screening children for high serum cholesterol levels. , 1992, Pediatrics.

[243]  H. Faigel.  Screening college students for hypercholesterolemia. , 1992, Journal of American college health : J of ACH.

[244]  B. Larsson,et al.  Cholesterol screening of seven‐year‐old children. How to identify children at risk , 1992, Acta paediatrica.

[245]  M. Becker,et al.  Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate. , 1992, Pediatrics.

[246]  D. Driscoll,et al.  Loss of dental enamel in a patient taking cholestyramine. , 1991, Mayo Clinic proceedings.

[247]  Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. , 1991, BMJ.

[248]  L. Neinstein,et al.  Hypercholesterolemia in adolescents: effectiveness of screening strategies based on selected risk factors. , 1991, Pediatrics.

[249]  D. Labarthe,et al.  Cholesterol screening in pediatric practice. , 1991, Pediatrics.

[250]  J. Van Camp,et al.  Family history fails to detect the majority of children with high capillary blood total cholesterol. , 1991, The Journal of school health.

[251]  Craig K. Ewart,et al.  Child problem solving competence, behavioral adjustment and adherence to lipid-lowering diet. , 1990, Patient education and counseling.

[252]  S. Joseph,et al.  Screening 1140 Fifth Graders For Hypercholesterolemia: Family History Inadequate To Predict Results , 1990, The Journal of the American Board of Family Medicine.

[253]  C. Basch,et al.  Failure of family history to predict high blood cholesterol among hispanic preschool children. , 1990, Preventive medicine.

[254]  D. Moodie,et al.  Routine cholesterol surveillance in childhood. , 1989, Pediatrics.

[255]  S. Srinivasan,et al.  Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children. , 1989, The Journal of pediatrics.

[256]  D. Wilcken,et al.  Screening for Familial Hypercholesterolemia in 5000 Neonates: A Recall Study , 1988, Pediatric Research.

[257]  D. Wilcken,et al.  A neonatal screening approach to the detection of familial hypercholesterolaemia and family-based coronary prevention , 1988, Journal of Inherited Metabolic Disease.

[258]  C. Glueck,et al.  Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia. , 1986, Pediatrics.

[259]  J. Lloyd,et al.  Double blind trial of bezafibrate in familial hypercholesterolaemia. , 1985, Archives of disease in childhood.

[260]  D. Kenny,et al.  Failure of cord serum cholesterol and betalipoprotein as screening tests for familial hyperlipoproteinaemia , 1984, Irish journal of medical science.

[261]  P. Groot,et al.  THE EFFECTS OF COLESTIPOL HYDROCHLORIDE ON SERUM LIPOPROTEIN LIPID AND APOLIPOPROTEIN B AND A‐I CONCENTRATIONS IN CHILDREN HETEROZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA , 1983, Acta paediatrica Scandinavica.

[262]  B. Joffe,et al.  Treatment of homozygous familial hypercholesterolaemia with probucol. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[263]  G. A. Hudson,et al.  Quantitation of beta-lipoprotein in cord serum by rate nephelometric immunoassay: a potential screening test for familial hypercholesterolemia. , 1982, Clinical chemistry.

[264]  M. Rosseneu,et al.  A screening procedure for dyslipoproteinemia in the newborn. Apoprotein quantitation on dried blood spots. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[265]  G. Heiss,et al.  Assessment of plasma total cholesterol as a test to detect elevated low density (beta) lipoprotein cholesterol levels (type IIa hyperlipoproteinemia) in young subjects from a population-based sample. , 1982, American journal of epidemiology.

[266]  G. Siest,et al.  Biological variations in hyperlipidemic children and adolescents treated with fenofibrate. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[267]  J. Dussault,et al.  Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults. , 1980, The Journal of clinical endocrinology and metabolism.

[268]  M. Rosseneu,et al.  EVOLUTION OF LIPOPROTEIN PATTERNS IN NEWBORNS , 1980, Acta paediatrica Scandinavica.

[269]  C. Glueck,et al.  beta-Lipoprotein quantitation in cord blood spotted on filter paper: a screening test. , 1980, Clinical chemistry.

[270]  G. Schonfeld,et al.  Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol. , 1980, Pediatrics.

[271]  T. Boulton.  The validity of screening for hypercholesterolaemia at different ages from 2 to 17 years. , 1979, Australian and New Zealand journal of medicine.

[272]  B. Friis‐Hansen,et al.  SCREENING FOR HYPERLIPOPROTEINEMIA IN 10 000 DANISH NEWBORNS Follow‐up Studies in 522 Children with Elevated Cord Serum VLDL‐LDL‐Cholesterol , 1979, Acta paediatrica Scandinavica.

[273]  G. E. Andersen,et al.  Familial hypobetalipoproteinaemia in 9 children diagnosed as the result of cord blood screening for hypolipoproteinaemia in 10 000 Danish newborns. , 1979, Archives of disease in childhood.

[274]  M. Malloy,et al.  Familial hypercholesterolemia in children: treatment with p-aminosalicylic acid. , 1978, Pediatrics.

[275]  C. Glueck,et al.  Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months. , 1977, Pediatrics.

[276]  P. Kwiterovich,et al.  DOSE-EFFECT RELATION OF CHOLESTYRAMINE IN CHILDREN AND YOUNG ADULTS WITH FAMILIAL HYPERCHOLESTEROLÆMIA , 1977, The Lancet.

[277]  J. Desager,et al.  Colestipol in familial type II hyperlipoproteinemia: A three‐year trial , 1976, Clinical pharmacology and therapeutics.

[278]  G. E. Andersen,et al.  Neonatal screening for hyperlipoproteinemia. Methods for direct estimation of cord serum VLDL + LDL. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[279]  J. Lloyd,et al.  The effect of cholestyramine on intestinal absorption. , 1975, Gut.

[280]  A. Motulsky,et al.  Plasma lipid levels and coronary heart disease in adult relatives of newborns with normal and elevated cord blood lipids. , 1974, American journal of human genetics.

[281]  C. Glueck,et al.  Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin. , 1974, Pediatrics.

[282]  C. Glueck,et al.  Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin. , 1973, Pediatrics.

[283]  J. Lloyd,et al.  Use of cholestyramine in treatment of children with familial hypercholesterolaemia , 1973, Archives of disease in childhood.

[284]  J. Lloyd,et al.  Prospective Study of Serum Cholesterol Levels during First Year of Life* , 1972, British medical journal.

[285]  Sonia Shah,et al.  Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries. , 2015, Clinical chemistry.

[286]  S. Humphries,et al.  Statins for children with familial hypercholesterolemia. , 2014, The Cochrane database of systematic reviews.

[287]  A. Mohn,et al.  Influence of the Mediterranean diet on carotid intima-media thickness in hypercholesterolaemic children: a 12-month intervention study. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[288]  R. Kelishadi,et al.  Effect of Hibiscus sabdariffa Calices on Dyslipidemia in Obese Adolescents: A Triple-masked Randomized Controlled Trial , 2013, Materia socio-medica.

[289]  R. Kelishadi,et al.  Effect of Zizyphus jujuba fruits on dyslipidemia in obese adolescents: a triple-masked randomized controlled clinical trial. , 2013, Medical archives.

[290]  D. Précoma,et al.  Household cardiovascular screening in adolescents from high-risk families. , 2013, Atherosclerosis.

[291]  M. Bourbon,et al.  Hypercholesterolemia--a disease with expression from childhood. , 2013, Revista Portuguesa de Cardiologia.

[292]  S. Yamashita,et al.  Guidelines for the management of familial hypercholesterolemia. , 2012, Journal of atherosclerosis and thrombosis.

[293]  G. Mowatt,et al.  Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation. , 2012, Health technology assessment.

[294]  M. Azarpazhooh,et al.  Effects of statin therapy on serum trace element status in dyslipidemic patients: results of a randomized placebo-controlled cross-over trial. , 2012, Clinical laboratory.

[295]  Supreet Kaur,et al.  Dyslipidemia amongst Obese Children in National Capital Territory (NCT) of Delhi , 2011, Indian journal of pediatrics.

[296]  J. Kastelein,et al.  Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin. , 2011, Journal of clinical lipidology.

[297]  M. Taskinen,et al.  ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, Atherosclerosis.

[298]  J. Defesche.  NLA Symposium on Familial Hypercholesterolemia Defining the challenges of FH Screening for familial hypercholesterolemia , 2010 .

[299]  Z. Kerem,et al.  Soy-derived Isoflavones Treatment in Children with Hypercholesterolemia: A Pilot Study , 2010, Journal of pediatric endocrinology & metabolism : JPEM.

[300]  E. Sijbrands,et al.  UvA-DARE ( Digital Academic Repository ) Two Years after Molecular Diagnosis of Familial Hypercholesterolemia : Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment , 2010 .

[301]  W. Neal,et al.  Body mass index as a surrogate measure of cardiovascular risk factor clustering in fifth-grade children: results from the coronary artery risk detection in the Appalachian Communities Project. , 2009, International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity.

[302]  O. Mayer,et al.  Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1. , 2009, Physiological Research.

[303]  J. Viikari,et al.  Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study , 2008, Circulation.

[304]  A. Montali,et al.  Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening. , 2008, Atherosclerosis.

[305]  Roya Kelishadi,et al.  Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study. , 2008, Journal of the American Dietetic Association.

[306]  Two controversial recommendations: screening (and treating) children for cholesterol... , 2008, Child health alert.

[307]  M. Daga,et al.  Lipid Pentad Index: A novel bioindex for evaluation of lipid risk factors for atherosclerosis in young adolescents and children of premature coronary artery disease patients in India. , 2007, Clinical biochemistry.

[308]  S. Humphries,et al.  HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEWS Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review , 2004 .

[309]  Y. Schlussel,et al.  Obese Children Should Be Screened for Hypercholesterolemia , 1996, Journal of health care for the poor and underserved.

[310]  S. Emans,et al.  Cholesterol screening in the adolescent. , 1993, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[311]  S. Hunt,et al.  Prevention of familial cardiovascular disease by screening for family history and lipids in youths. , 1992, Clinical chemistry.

[312]  M. Sánchez Bayle,et al.  Is a parental history of coronary arterial disease in children as discriminating as their lipoprotein profile? Niño Jesus Group. , 1992, International journal of cardiology.

[313]  S. Shea,et al.  Family history fails to identify many children with severe hypercholesterolemia. , 1991, American journal of diseases of children.

[314]  M. K. Park,et al.  Predictive value of family history in detecting hypercholesterolemia in predominantly Hispanic adolescents. , 1991, Texas medicine.

[315]  K. Schneider,et al.  Effectiveness of education-screening on cholesterol levels of students. , 1991, Annals of nutrition & metabolism.

[316]  E. Stein.  Treatment of familial hypercholesterolemia with drugs in children. , 1989, Arteriosclerosis.

[317]  E. Diamond,et al.  Screening for hypercholesterolemia in college students. , 1989, Journal of American college health : J of ACH.

[318]  D. M. Davidson,et al.  School-based blood cholesterol screening. , 1989, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[319]  J. Vobecky,et al.  Dietary habits in relation to tracking of cholesterol level in young adolescents: a nine-year follow-up. , 1988, Annals of nutrition & metabolism.

[320]  J. Van Biervliet,et al.  Screening and follow-up of infants with dyslipoproteinemia. , 1985, Progress in clinical and biological research.

[321]  P. Kwiterovich,et al.  A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia. , 1977, Advances in experimental medicine and biology.

[322]  J. Lloyd,et al.  Treatment of children with familial hypercholesterolaemia. , 1975, Postgraduate medical journal.

[323]  Mingyao Li,et al.  For Personal Use. Mass Reproduce Only with Permission from Mayo Clinic Proceedings. for Personal Use. Mass Reproduce Only with Permission from Mayo Clinic Proceedings. Simvastatin Vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial , 2022 .

[324]  N. Braun,et al.  Vascular Health and Risk Management Dovepress Computerized History-taking as a Tool to Manage Dyslipidemia , 2022 .

[325]  L. Conwell,et al.  Vascular Health and Risk Management Dovepress Considering Statins for Cholesterol-reduction in Children If Lifestyle and Diet Changes Do Not Improve Their Health: a Review of the Risks and Benefits , 2022 .

[326]  RESEARCH ARTICLE Open Access Prevalence of the Metabolic Syndrome among , 2022 .